Gianni B. Scappaticci

Risk factors and impact of Clostridium difficile recurrence on haematology patients

Gianni B. Scappaticci, Anthony J. Perissinotti, Jerod Nagel et al. · Journal of Antimicrobial Chemotherapy · 2017 · 38 citations · Full text

The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia

Vera Vulaj, Anthony J. Perissinotti, James R. Uebel et al. · Leukemia Research · 2018 · 25 citations

Hematological Malignancy, Oncology, Induction Therapy +9

Defibrotide Therapy for SARS-CoV-2 ARDS

David Frame, Gianni B. Scappaticci, Thomas Braun et al. · CHEST Journal · 2022 · 14 citations · Full text

Antiviral Drug Development, Antiviral Therapy, Virology +5

Incorporating preauthorization into antimicrobial stewardship pharmacist workflow reduces <i>Clostridioides difficile</i> and gastrointestinal panel testing

Nikki Tran, John Mills, Christopher Zimmerman et al. · Infection Control and Hospital Epidemiology · 2020 · 12 citations

Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy

Amy L. Pasternak, Lauren A. Marcath, Yajing Li et al. · Transplantation and Cellular Therapy · 2021 · 12 citations · Full text

Oral Therapy, Pharmacotherapy, Tacrolimus Exposure +25